Transcutaneous cervical esophagus ultrasound in adults: Relation with ambulatory 24-h pH-monitoring and esophageal manometry

Table 1 Demographic and TCEUS findings in groups divided according to pH monitoring (mean ± SD)

	Group A (n = 20)	Group B (n = 6)	Group C (n = 6)	Group D (n = 8)	Group E (n = 13)	Group F (n = 5)	Group B + D (n = 14)	Group E + F (n = 18)	Group A + F (n = 25)	P
Age (yr)	43.4 ± 12.0	40.0 ± 11.4	47.8 ± 12.7	42.6 ± 12.5	43.17 ± 9.6	37.2 ± 18.8	41.5 ± 11.7	40.5 ± 10.7	42.3 ± 13.7	NS
	(24-72)	(24-58)	(38-72)	(25-62)	(25-65)	(15-64)	(24-629	(16-65)	(15-72)
Sex (F/M)	8/12	3/3	1/5	4/4	11/2	5/0	7/7	2/16	12/13	NS
n (%)	(40/60)	(50/50)	(16.7/83.3)	(50/50)	(84.6/5.4)	(100/0)	(50/50)	(88.9/11.1)	(52/48)
BMI (kg/m2)	27.4 ± 4.5	27.4 ± 4.4	27.4 ± 4.4	27.9 ± 5.6	27.7 ± 4.6	24.9 ± 2.1	27.7 ± 4.9	26.9 ± 4.24	26.9 ± 4.3	NS
	(19.6-37.4)	(19.6-32)	(19.6-32)	(20.6-37.5)	(17.6 ± 35.0)	(22.7-27.4)	(19.6-37.4)	(17.6-35.0)	(19.6-37.5)
ED (mm)	9.4 ± 1.4	9.7 ± 0.9	9.1 ± 1.6	9.6 ± 1.71	8.54 ± 1.82	10.6 ± 1.3	9.6 ± 1.4	9.1 ± 1.9	9.7 ± 1.5	NS
	(6.1-12.1)	(8.2-10.8)	(8.0-12.0)	(6.1-11.4)	(5.5-11.1)	(8.8-12.4)	(6.2-11.4)	(5.5-12.4)	(6.1-12.4)
ELD (mm)	5.0 ± 1.2	5.1 ± 1.1	4.6 ± 1.6	5.2 ± 1.18	3.9 ± 1.4	5.3 ± 1.7	5.16 ± 1.10	4.3 ± 1.6	5.0 ± 1.3	0.023a
	(3.0-7.7)	(3.00-6.00)	(3.4-7.7)	(3.0-6.4)	(1.5-6.2)	(3.4-7.9)	(3.0-6.4)	(1.5-7.9)	(3.0-7.9)
Esophageal	2.2 ± 0.2	2.3 ± 1.2	2.2 ± 0.1	2.1 ± 0.3	2.3 ± 0.3	2.6 ± 0.7	2.2 ± 0.3	2.4 ± 0.50	2.3 ± 0.4	NS
WT (mm)	(1.5-2.6)	(2.2-2.6)	(2.0-2.3)	(1.5-2.5)	(2.0-3.3)	(2.2-4.0)	(1.6-2.6)	(2.0-4.0)	(1.6-4.0)
DeMeester	19.5 ± 12.1	7.9 ± 3.1	24.3 ± 14.4	24.5 ± 9.1	6.4 ± 4.7	7.5 ± 4.9	17.4 ± 10.9	6.7 ± 4.7	17.7 ± 11.8	NS
score	(1.7-46.2)	(4.6-13.2)	(1.7-46.2)	(14.4-38.9)	(0.8-14.7)	(1.4-17.3)	(4.6-38.9)	(0.8-14.7)	(1.4-46.2)

TCEUS: Transcutaneous cervical esophagus ultrasonography; ED: Esophageal diameter; ELD: Esophageal luminal diameter; Esophageal WT: Esophageal wall thickness; BMI: Body mass index.

^aP < 0.05 between group A + F and group E. NS: Non-significant.